Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples